Supervised aerobic, resistance exercise tied to improved lean mass, muscle strength, and physical performance.

There was no significant difference in survival outcomes for patients with advanced neuroendocrine tumors who were treated with low-dose everolimus compared to standard-dose everolimus, according to a ...

Study researchers noted that the findings suggest the association between anxiety and improved OS was at least partly related to the higher incidence of irAEs, which implies that, in people with an ...

Findings showed both zanidatamab treatment arms demonstrated statistically significant and clinically meaningful improvements in PFS vs the SOC arm.

A review of EMR data from younger and older women with breast cancer noted that social support was not consistently documented among patients.

The treatment effects on PFS were consistent regardless of modeling approach and for both targeted and nontargeted therapies.

To our knowledge, this is the greatest survival benefit, based upon hazard ratio, ever seen in a prostate cancer,” said study presenter Stephen J. Freedland, MD.

The Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory ...

Thrombosis occurs in more than 1 in 10 adults receiving PEGylated asparaginase (Asp)–based therapy for acute lymphoblastic leukemia (ALL), with a 4-fold ...

Funding accounted for 34.5 percent of total financial assistance requested in campaigns initiated between Jan. 1, 2021, and Feb. 28, 2023.

Researchers explored whether a direct-to-patient digital intervention could increase the number of lung cancer screening CTs among patients in 2 US health systems.

HealthDay News — Multicancer early detection (MCED) tests can increase earlier-stage diagnoses and reduce late-stage diagnoses, according to a study published online Nov. 10 in Cancer.